About Innoviva (INVA)
Innoviva, Inc., formerly Theravance, Inc., is engaged in the development, commercialization and financial management of bio-pharmaceuticals. It focuses on the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA ... Read more
- USD15.01
- USD15.13
- USD14.98
- USD16.87
- -0.70%
- 310M
- 40.28k
- 652.84k
- 945M
- 11.37
- 27.80%
- 18.50%
Stock News
2 hours ago
Align Technology, Inc. (NASDAQ:ALGN) Q1 2024 Earnings Call Transcript
Yahoo
2 hours ago
Align Technology Announces $150 Million Open Market Repurchase
Yahoo
2 hours ago
Burke & Herbert Financial Services Corp. Announces First Quarter 2024 Results and Declares Common Stock Dividend
Yahoo
3 hours ago
Imperial Oil reports higher production, lower refinery throughput in Q1
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
